Department of Pathology, Maulana Azad Medical College, New Delhi, India.
Department of Pathology, Government Medical College and Hospital, Chandigarh, India.
Diagn Cytopathol. 2022 Oct;50(10):463-470. doi: 10.1002/dc.25017. Epub 2022 Jul 23.
Fine-needle aspiration cytology (FNAC) forms one of the first-line investigations in the evaluation of tumors in modern era. Its role in diagnosing soft tissue tumors (STT) has been well established. However, the morphological overlap and biological heterogeneity of STT pose a morphological diagnostic challenge.
To evaluate the scope of FNAC in diagnosis and categorization of STT and to correlate the cytological features with histological findings wherever available, and to analyze the reasons for discordance, if any.
All FNAs of cytologically diagnosed STT during 5-year period were retrospectively analyzed. FNAC smears stained using May-Grünwald Giemsa, Pap- and hematoxylin and eosin, were evaluated and interpreted inconjunction with clinical details. Cellblock and immunocytochemistry (ICC) was done, wherever required to render the final diagnosis.
Of the total 15,844 FNAC done in 5 years, 1319 (8.3%) cases were diagnosed as STT. Benign tumors comprised the majority (94.2%), whereas 5.8% were diagnosed to be malignant. These were further grouped according to the cytomorphological features into adipocytic (82.2%), benign spindle cell lesions (10.8%), vascular (1.4%), spindle cell sarcoma/sarcoma NOS (2.2%), myxoid (0.3%), round cell tumors (0.9%), metastatic tumors (1.9%), and others (0.3%). The cytological findings were corelated with histopathological findings, which were available in 316 cases. The specificity and sensitivity calculated for detecting malignancy was 99.2% and 95.4%, respectively. The overall diagnostic accuracy for diagnosing malignancy was 98.7%. Among the group of non-adipocytic tumors, the sensitivity, specificity, PPV, NPV calculated for diagnosing a malignant tumor (irrespective of exact sub-categorization) is 95.2%, 100%, 100%, and 96.4%, respectively. The overall diagnostic accuracy in non-adipocytic tumors is 97.92%.
FNAC is a simple, cost effective, and minimally invasive method in diagnosing STT with good sensitivity and specificity. It is of utility not only in primary lesions, but also for metastatic tumors, and for the documentation of locally recurrent soft tissue neoplasms.
细针穿刺细胞学检查(FNAC)是现代时代评估肿瘤的一线检查之一。它在诊断软组织肿瘤(STT)中的作用已得到充分确立。然而,STT 的形态重叠和生物学异质性构成了形态学诊断的挑战。
评估 FNAC 在诊断和分类 STT 中的范围,并尽可能将细胞学特征与组织学发现相关联,并分析任何不相符的原因。
回顾性分析了 5 年内细胞学诊断为 STT 的所有 FNAs。使用迈-格-鲁姆瓦尔德-吉姆萨、巴氏和苏木精-伊红染色对 FNAC 涂片进行染色,并结合临床详细信息进行评估和解释。在需要时进行细胞块和免疫细胞化学(ICC),以做出最终诊断。
在 5 年内进行的总共 15844 次 FNAC 中,有 1319 例(8.3%)被诊断为 STT。良性肿瘤占多数(94.2%),而 5.8%被诊断为恶性。根据细胞学形态特征进一步分为脂肪细胞(82.2%)、良性梭形细胞病变(10.8%)、血管(1.4%)、梭形细胞肉瘤/肉瘤 NOS(2.2%)、黏液样(0.3%)、圆形细胞肿瘤(0.9%)、转移性肿瘤(1.9%)和其他(0.3%)。细胞学发现与组织病理学发现相关,其中 316 例有组织病理学发现。计算出检测恶性肿瘤的特异性和敏感性分别为 99.2%和 95.4%。诊断恶性肿瘤的整体诊断准确性为 98.7%。在非脂肪细胞肿瘤组中,诊断恶性肿瘤(无论是否进行精确亚分类)的敏感性、特异性、PPV、NPV 分别为 95.2%、100%、100%和 96.4%。非脂肪细胞肿瘤的整体诊断准确性为 97.92%。
FNAC 是一种简单、经济有效的微创方法,用于诊断 STT,具有良好的敏感性和特异性。它不仅在原发性病变中有用,而且对转移性肿瘤和局部复发性软组织肿瘤的诊断也很有用。